When diet and exercise are not enough to lower blood sugar, doctors usually first prescribe a drug such as metformin. However, many patients diagnosed with type 2 diabetes need a second or even third blood- sugar lowering drug to maintain a desirable blood sugar level.
The SOTA-MET research study will assess the effectiveness of an investigational drug, when combined with metformin, for the potential management of type 2 diabetes.
About the Study
Researchers will assess if the investigational drug can help to lower hemoglobin A1C, a test that measures how well blood sugar is controlled over time.
The study consists of 14 total visits to the Pennington Biomedical outpatient clinic. These visits will take place over a period of approximately 1 year and 9 months. Study participants will receive diet, exercise and diabetic testing instructions over the course of the study.
- 14 total visits
- Medical history
- Height and weight
- Vital signs (pulse and blood pressure)
- Blood tests
- Electrocardiogram (ECG) to determine heart health
Number of Visits:
- Be 18 years of age or older
- Have been diagnosed with type 2 diabetes
- Have been taking metformin for at least 12 weeks prior to screening for this study
- Have a BMI of greater than 20 and less than or equal to 45 calculate your BMI
To qualify for this research study, participants should:
Study DurationParticipation in this study will last approximately 1 year and 9 months.
CompensationCompensation for time and travel may be available.
Study ContactIf you are interested in volunteering for this research study, click here to screen online, call 225-763-3000 or email email@example.com.
If you think you may be eligible, please click the button below to screen online.GET STARTED
Please do not fill out this questionnaire for anyone other than yourself unless you are their legal guardian.
If you know someone who may be interested please direct them to the site or have them call us directly at 225-763-3000.